Albert David Limited (ALBERTDAVD) — unitholding pattern
The board approved the appointment of Amit Mahla as an additional director effective June 19, 2026, and as a whole-time director and CEO for five years until June 18, 2031, subject to shareholder approval at the upcoming 87th AGM. The notice for the AGM was revised to include these matters. The appointment follows his prior role as CEO since May 12, 2026, and reflects a strategic leadership addition with extensive pharmaceutical industry experience.
About Albert David Limited (ALBERTDAVD)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when ALBERTDAVD files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ALBERTDAVD — Free💡 Ask AI about this filing
📊 More ALBERTDAVD filings
- Announcement — 4 July 2026 Albert David Limited announced the resignation of Cluster-Head Mr. Saikath Banerjee effective July 4...
- share transfer — 4 July 2026 Albert David Limited received a compliance certificate from its share transfer agent covering the pe...
- 🟡 Board Meeting — 4 July 2026 No summary available
- 🔴 Announcement — 26 June 2026 Albert David Limited received a credit rating downgrade from CARE Ratings on its bank facilities, re...
- Financial Results — 23 June 2026 Albert David Limited announced that its trading window will close on 1 July 2026 in compliance with ...
🔥 Also filed on 19 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when ALBERTDAVD files new disclosures
Track ALBERTDAVD filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ALBERTDAVD — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research